|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02279 YONGHE MEDICAL
Nominal 
2.740 +0.030 (+1.107%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 861,550 | -4.294% | 900,203 | 827,807 | 748,137 | 1,053,400 |
| Cost of Sales | (311,227) | -16.058% | (370,766) | (360,209) | (267,641) | (277,983) |
| Gross Profit | 550,323 | 3.945% | 529,437 | 467,598 | 480,496 | 775,417 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | (14,064) | -- | -- | -- | |
| Change in FV & Impairment on Others | (1,751) | 2088.750% | (80) | (276) | 90 | (376) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 37,809 | -- | (146,699) | (256,428) | 13,274 | 88,875 | |
| Taxation | (9,954) | -- | 8,051 | 30,237 | 4,355 | (48,434) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 58 | -23.684% | 76 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 27,913 | -- | (138,572) | (226,191) | 17,629 | 40,441 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 6,886 | -57.097% | 16,050 | 31,296 | (36,695) | 20,270 |
| Depreciation & Amortisation | 125,152 | -25.759% | 168,575 | 152,120 | 108,883 | 97,067 |
| Directors' Emoluments | -- | -- | -- | -- | -- | 1,023 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 6.000 | -- | -28.000 | -44.000 | 3.000 | 10.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 1.413 | -- | 1.526 | 2.407 | 3.429 | -- |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 27,913 |
| %Change | -- |
| EPS / (LPS) | RMB 0.060 |
| NBV Per Share (¥) | RMB 1.413 |